[First experiences with the use of dopamine (hydroxytyramine) in cardiogenic shock].
D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000150:complications; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology; D014655:Vascular Resistance / Q000187:drug effects
D004298:Dopamine
Erste Erfahrungen mit der Anwendung von Dopamin (Hydroxytyramin) beim kardiogenen Schock.